StockNews.com Initiates Coverage on Bio-Path (NASDAQ:BPTH) :

Equities researchers at StockNews.com started coverage on shares of Bio-Path (NASDAQ:BPTH – Get Rating) in a research report issued on Thursday. The firm set a “sell” rating on the stock. Separately, Roth Capital reaffirmed a “buy” rating on shares of Bio-Path in a report on Friday, March 17th. Bio-Path Stock Performance Shares of NASDAQ:BPTH opened […]

Related Keywords

Douglasp Morris , Peterh Nielsen , Gabriel Lopez Berestein , Path Company Profile , Nasdaq , Virtu Financial , Citadel Advisors , Renaissance Technologies , Path Holdings Inc , Get Rating , Roth Capital , Path Holdings , Ana Tari Ashizawa , Bio Path Daily , Bio Path , Nasdaq Bpth , Bpth , Medical , Initiated Coverage , Stocknews Com ,